A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing Alzheimer’s disease.

Award to Dr. Walter Swardfager, from Sunnybrook Research Institute, will support a proof-of-mechanism clinical trial ...

In people with Down syndrome, changes associated with Alzheimer's disease can begin long before the onset of severe cognitive ...

If the latter group improves significantly more than the former, that would allow scientists to say definitively: Yes, this ...

Learn the common signs of Alzheimer’s disease, how it progresses, and steps families can take for diagnosis and care.

A major focus of R&D in the Alzheimer’s disease therapeutic space is preventing the accumulation of amyloid beta.

Not all researchers are convinced that the brain changes detected via MRI are robust enough to become a diagnostic tool. But ...

A multidisciplinary care model developed across Sutter Health helped general neurologists address a practical challenge ...

Women account for nearly two-thirds of Americans living with Alzheimer's disease. Why they are disproportionately affected remains an important question in brain health research, and scientists at ...

A small study once suggested that differences between the two nostrils in detecting peanut butter might offer a clue to ...

Oklahoma Sen. Mark Mann wants to bring an Alzheimer's research center to the state. 70K+ Oklahomans 65+ are living with the ...

New research links karyoptosis in Alzheimer’s disease to nuclear collapse, offering potential therapeutic targets to slow ...